Home ATXI
2.6544
  Price57.80%   -3.6356
 
loading
Revenue
loading
Net Income
loading
Cash Flow
loading
EPS
loading
Debt to Equity Ratio
loading
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was founded in 2015 and is based in New York, New York.
Cap:    |  Volume (24h):